Detalhe da pesquisa
1.
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team.
Hepatol Res
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571477
2.
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Invest New Drugs
; 41(3): 512-521, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171720
3.
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury.
J Gastroenterol Hepatol
; 38(2): 251-258, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302734
4.
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Cancer Invest
; 40(2): 189-198, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34658277
5.
Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers.
Molecules
; 26(4)2021 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33562410
6.
Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response.
Clin Infect Dis
; 70(6): 1208-1214, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056696
7.
The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.
Liver Int
; 39(3): 448-454, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312003
8.
Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infection.
Hepatol Res
; 49(5): 512-520, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30628746
9.
Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
Liver Int
; 38(12): 2260-2268, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981527
10.
Significance of day-1 viral response of hepatitis C virus in patients with chronic hepatitis C receiving direct-acting antiviral therapy.
J Gastroenterol Hepatol
; 33(6): 1264-1270, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164675
11.
Differences in the impact of prognostic factors for hepatocellular carcinoma over time.
Cancer Sci
; 108(12): 2438-2444, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945309
12.
Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
J Gastroenterol Hepatol
; 32(12): 1982-1988, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28299813
13.
Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center.
Clin Nutr
; 43(6): 1425-1432, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703510
14.
Imaging basis of AFP and WFA+M2BP as indicators of the risk of HCC after SVR.
J Hepatol
; 68(3): 606-607, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079286
15.
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 15(10)2023 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345189
16.
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
J Gastroenterol
; 58(6): 565-574, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991155
17.
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies.
Hepatol Int
; 15(5): 1278-1287, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373964
18.
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies.
J Gastroenterol
; 55(6): 653-661, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124082
19.
The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma.
J Gastroenterol
; 54(9): 829-836, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161311
20.
The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C.
Aliment Pharmacol Ther
; 50(11-12): 1232-1238, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31588590